Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?
about
Substitution treatment for opioid addicts in GermanyTangible resources for preparing patients for antiviral therapy for chronic hepatitis CInterferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disordersA randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment.Barriers to treatment of hepatitis C in HIV/HCV-coinfected adults with alcohol problems.Immune response in addicts with chronic hepatitis C treated with interferon and ribavirin.Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services.High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US citiesIdentification of substance use and dependence among patients with viral hepatitis.Controversies in and challenges to our understanding of hepatitis C.Psychiatric care of the patient with hepatitis C: a review of the literature.Hepatitis infection in the treatment of opioid dependence and abuse.Hepatitis C treatment of patients with bipolar disorder: a case seriesThe acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users.On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial.Treatment of intravenous drug users with chronic hepatitis C: treatment response, compliance and side effects.Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health/substance abuse issues.Perceptions of drug users regarding hepatitis C screening and care: a qualitative studyThe Effect of Peginterferon Alpha-2a vs. Peginterferon Alpha-2b in Treatment of Naive Chronic HCV Genotype-4 Patients: A Single Centre Egyptian StudyTreatment of chronic hepatitis C infection among current and former injection drug users within a multidisciplinary treatment model at a community health centreCritical issues in the treatment of hepatitis C virus infection in methadone maintenance patients.Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S.Current approaches to HCV infection in current and former injection drug users.Interferon-based hepatitis C treatment in patients with pre-existing severe mental illness and substance use disorders.Opioids and HIV/HCV infection.Improving access to treatment for patients with chronic hepatitis C through outreach.Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype-4 chronic hepatitis C patients.Characteristics of chronic hepatitis C among intravenous drug users: a comparative analysisEfficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment.Meeting the physical health-care needs of people with substance misuse problems: evaluation of a nurse-led blood-borne virus programme.Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities.Hospitalization due to alcohol and drug abuse in first- and second-generation immigrants: a follow-up study in Sweden.UEG Week 2015 Poster PresentationsHepatitis C virus prevention and care for drug injectors: the French approach
P2860
Q24676064-3A4EC660-8E5F-4552-BDBE-58DE9DE30A5DQ26858962-6DC61C3C-9054-47D9-A2E3-8C93D9CD1F72Q27477998-CB51FCD9-04AF-4B4E-8CC9-522DAA29346CQ30540697-E5A856DE-0A44-4CCF-A57A-18A1C820AAF9Q33255104-A543A03D-CE42-4134-95BE-8BFD3185402AQ33268083-777A38F7-2DC2-4B48-9C4D-FABFE2EE8265Q33277431-1693F3E0-838A-4611-A5A3-4BC123B9CDC1Q33989662-AA6AD432-5738-40DD-AA59-AB3900B0B22DQ34023364-ACA624F6-FE04-471C-A522-FEB014C38F0BQ34604806-F9F0A84B-89DE-4991-9127-7D0883784EF8Q34743058-C5B5B743-A204-4D47-A44D-1BE8103D7C15Q35389163-703F3067-1E7B-42CB-86DB-3B17A19EC85FQ35574487-8676F20C-07D9-4CC9-B322-70B49C6A9BDDQ36535234-1A4C2649-5C4C-4B98-9880-83E5331EBA12Q36646287-6BA9D673-1CA3-4617-A389-73D09C6FD304Q36908024-41CEFB9F-DCCE-464C-A70C-5C813DBA3294Q36933104-A09A75D0-664B-4E07-988B-ACEDBE668F46Q36964408-F91D04A0-5F59-47F7-8045-56AEBED0B913Q37067776-8BC542FB-415E-4B62-A7C1-0080AA31C110Q37092648-2354E2ED-F8E5-4866-A41A-559F337794E1Q37142229-C09EEFED-CB95-41A4-BBF4-55DADC1D9342Q37232639-7C5C4200-9A65-42B9-B49B-5FBAEE4307ECQ37235530-045F009B-8BA1-4224-847E-E40EC481246AQ37432112-E7A77676-C2F1-4AC6-A736-0FF5E6FBFFC9Q37607856-F8017842-F1EE-4AC5-B3E8-F407638EDB22Q38609143-9E405CD2-E382-4185-9AD3-7900BA8E331AQ39062828-289C37C8-A138-4CD7-9952-75DE078F15A6Q41008122-2C93768C-3073-438A-9D01-F3B1875841E1Q43041036-F6B61F96-261B-4ECB-B97A-E67A84DAF8A3Q45358053-044EF5D6-7DA3-4894-A76B-07ADF6273F2BQ45420303-7CF359D0-BF5E-46D2-B6B2-B88E000B4F7BQ46934890-7152A4FC-A5B5-447A-A62A-AA4067AF6D38Q56934656-88B05FE2-BD43-4818-972C-D1BE27ED3B4DQ57144432-F1729C14-7F65-46C6-B5A5-E25ED54D805A
P2860
Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Treatment of chronic hepatitis ...... nce: time to change the rules?
@ast
Treatment of chronic hepatitis ...... nce: time to change the rules?
@en
type
label
Treatment of chronic hepatitis ...... nce: time to change the rules?
@ast
Treatment of chronic hepatitis ...... nce: time to change the rules?
@en
prefLabel
Treatment of chronic hepatitis ...... nce: time to change the rules?
@ast
Treatment of chronic hepatitis ...... nce: time to change the rules?
@en
P2093
P1433
P1476
Treatment of chronic hepatitis ...... nce: time to change the rules?
@en
P2093
Andreas Heinz
Markus Backmund
Martin Schaefer
P304
P356
10.1111/J.1360-0443.2004.00821.X
P407
P577
2004-09-01T00:00:00Z